Corticosteroid plus β2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis

Corticosteroid plus β2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis

Abstract Background Current guidelines recommend a single inhaler maintenance and reliever therapy (SMART) regimen for moderate to severe asthma. However, evidence for the inhaled corticosteroid plus fast-onset-acting β2-agonist (ICS/FABA) as reliever therapy in management of intermittent and mild a...

Full description

Bibliographic Details
Main Authors: Gang Wang, Xin Zhang, Hong Ping Zhang, Lei Wang, De Ying Kang, Peter J. Barnes
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Respiratory Research
Subjects:
Combination of corticosteroid and fast-onset-acting β2-agonist
Inhaled corticosteroids
Short-acting β2-agonist
Meta-analysis
Online Access:http://link.springer.com/article/10.1186/s12931-017-0687-6

Internet

http://link.springer.com/article/10.1186/s12931-017-0687-6

Similar Items